For example: Apple Inc, UTIL, Aluminum
Mallinckrodt PLC
NYSE:MNK
Market Close 08/16
4.08 USD -0.01 (-0.24%)
OPEN:
4.10
DAY RANGE:
4.00 - 4.32
PE:
-0.22
PB:
0.46
PS:
0.21
WTD % -23.16
MTD % -40.09
QTD % -55.56
YTD % -74.18
* Updated at market close
Mallinckrodt PLC (NYSE:MNK) opened on Aug 16, 2019 at 4.10 USD and went marginally down by -0.24%. The intraday price range was 4.00 - 4.32 USD and eventually ended the session at 4.08 USD. The stock trade volume was 5.28 M shares. The company's 52-week range is 3.85 - 36.65 USD.
Trading Statistics (Market Close Aug 16, 2019)
Market Cap 341.96 M
Outstanding Stock 83.31 M
Dividend 0.00
Dividend Yield 0.00
EPS -40.95
YTD Change -74.18%
52 Week's Range 3.85 - 36.65
Key Ratio & Margins (Market Close Aug 16, 2019)
Price/Earning -0.22
Price/Book Value 0.46
Price/Sales 0.21
ROA -25.60%
ROE -64.30%
Debt/Equity 2.32
Company Self Description
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded pharmaceutical products in Canada and the European Union, as well as in Latin American, the Middle Eastern, African, and the Asia-Pacific regions. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies. It was founded in 1867 and is headquartered in Staines, United Kingdom.
Business Information
Mallinckrodt PLC
Sector Health Care
Industry Pharmaceuticals
Exchange NYSE
Top Competitors (Market Close Aug 16, 2019)
  MNK AKRX PRVB OBSV
Daily Change (%) -0.24 5.86 -0.86 0.68
WTD (%) -23.16 -9.67 -4.05 0.11
MTD (%) -40.09 -27.15 -12.59 -1.67
QTD (%) -55.56 -47.38 -23.72 -21.84
YTD (%) -74.18 -20.06 421.47 -30.17
52-Week Change (%) -88.05 -85.85 136.67 -29.39
Stock Performance (Market Close Aug 16, 2019)
  MNK AKRX PRVB OBSV
Daily Change (%) -0.24 5.86 -0.86 0.68
WTD (%) -23.16 -9.67 -4.05 0.11
MTD (%) -40.09 -27.15 -12.59 -1.67
QTD (%) -55.56 -47.38 -23.72 -21.84
YTD (%) -74.18 -20.06 421.47 -30.17
52-Week Change (%) -88.05 -85.85 136.67 -29.39
Key Fundamentals (Market Close Aug 16, 2019)
  MNK AKRX PRVB OBSV
Market Cap 341.96 M 341.05 M 344.85 M 328.24 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -95.00% -72.20% 0.00 0.00
P/E Ratio -0.22 -1.35 -15.92 -6.63
Price to Sales Ratio 0.21 0.98 0 0
Price to Book Ratio 0.46 0.96 1.11 3.20
Enterprise Value to EBITDA -2.57 -3.13 -0.07 -4.69
ROA -25.60% -31.60% -61.30% -50.70%
ROE -64.30% -111.20% -64.60% -56.90%
Debt/Equity 2.32 2.37 0.03 0.14
Asset Turnover Ratio 0.31 0.44 0 0
Current Ratio 1.51 3.42 32.89 8.58
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 3.22 B 3.22 B 3.38 B 2.92 B
Cost Of Revenue 1.74 B 1.56 B 1.52 B 1.30 B
Gross Profit 1.47 B 1.66 B 1.86 B 1.62 B
Selling General & Administrative Expenses 834.10 M 849.70 M 913.70 M 1.02 B
Research & Development 361.10 M 276.90 M 261.20 M 203.30 M
Operating Income -3.72 B 492.90 M 633.10 M 353.80 M
Net Income -3.61 B 2.13 B 643.70 M 324.70 M
EPS -42.94 21.85 5.82 2.78
Diluted EPS -42.94 21.80 5.77 2.75
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 823.30 M 790.60 M 1.37 B 640.00 M
Cost Of Revenue 434.40 M 455.50 M 807.70 M 326.20 M
Gross Profit 388.90 M 335.10 M 563.60 M 313.80 M
Selling General & Administrative Expenses 225.90 M 230.20 M 313.40 M 164.00 M
Research & Development 79.60 M 85.30 M 137.20 M 78.50 M
Operating Income -29.90 M 15.40 M -3.79 B 56.00 M
Net Income 6.80 M 154.90 M -3.72 B 113.80 M
EPS 0.08 1.86 -44.26 1.37
Diluted EPS 0.08 1.83 -44.25 1.34
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 1.43 B 2.29 B 1.51 B 1.85 B
Cash & Cash Equivalents 348.90 M 1.26 B 280.50 M 365.90 M
Total Assets 10.88 B 15.28 B 15.50 B 16.40 B
Total Current Liabilities 943.70 M 1.05 B 1.23 B 929.40 M
Total Liabilities 7.99 B 8.76 B 10.23 B 11.09 B
Shareholder's Equity 2.89 B 6.52 B 5.27 B 5.31 B
Outstanding Stock 83.31 M 95.00 M 107.71 M 117.34 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 1.22 B 1.24 B 1.43 B 2.04 B
Cash & Cash Equivalents 241.10 M 225.80 M 348.90 M 290.70 M
Total Assets 10.22 B 10.56 B 10.88 B 14.91 B
Total Current Liabilities 1.56 B 854.00 M 943.70 M 922.60 M
Total Liabilities 7.15 B 7.50 B 7.99 B 8.31 B
Shareholder's Equity 3.08 B 3.05 B 2.89 B 6.60 B
Outstanding Stock 83.81 M 83.51 M 83.31 M 83.21 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations 665.50 M 727.30 M 1.18 B 930.50 M
Capital Expenditures -127.00 M -186.10 M -182.90 M -148.00 M
Net Cash Flow from Investing Activities -480.30 M 318.40 M -155.60 M -2.30 B
Net Cash Flow from Financial Activities -1.10 B -130.20 M -1.16 B 1.04 B
Free Cash Flow 538.50 M 541.20 M 1.00 B 782.50 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations 302.90 M 727.30 M 1.18 B 930.50 M
Capital Expenditures -37.80 M -39.80 M -33.70 M -26.20 M
Net Cash Flow from Investing Activities -30.00 M -39.40 M -29.10 M 5.10 M
Net Cash Flow from Financial Activities -258.00 M -248.40 M -96.10 M -169.60 M
Free Cash Flow 265.10 M 124.70 M 150.70 M 193.10 M
Key Ratios (Market Close Aug 16, 2019)
Valuation Ratios 2019 2018 2017 2016
P/E Ratio -0.22 -0.53 -0.37 1.64
Price to Sales Ratio 0.21 0.50 0.42 0.66
Price to Book Ratio 0.46 0.33 1.43 1.51
Enterprise Value to EBIT -2.00 10.00 17.00 29.00
Enterprise Value to EBITDA -2.57 4.75 8.27 11.72
Profitability Ratios 2019 2018 2017 2016
Revenue Growth - - - -
Net Income Growth - - - -
ROA -25.60% -25.60% 14.40% 1.80%
ROE -64.30% -64.30% 39.10% 5.40%
Liquidity Ratios 2019 2018 2017 2016
Working Capital 483.50 M 1.23 B 271.90 M 916.70 M
Current Ratio 1.51 2.18 1.22 1.99
Efficiency & Capital Structure Ratios 2019 2018 2017 2016
Debt Equity Ratio 2.32 1.34 1.94 2.09
Asset Turnover Ratio 0.23 0.23 0.22 0.20
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.